Adagio Medical Holdings, Inc.
ADGM· Nasdaq
ADGMAdagio Medical Holdings, Inc.
Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001558370-24-015720
| Metric | Q3 2024 | Q3 2023 |
|---|---|---|
| Revenue | $132.00K | $41.00K |
| Net Income | $3.61M | -$10.76M |
| EPS Diluted | $0.02 | -$14.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adagio Medical Holdings, Inc. · CIK 2006986 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end
